Fumaric Acid

Fumaric Acid

SCHEMBL3796830

CCON1C(C)(C)CC(OC(C)=O)CC1(C)C.O=C(O)C=CC(=O)O

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
KMT2A known ✓ Q03164 2/20 0.48
MEN1 known ✓ O00255 1/20 0.39
TSHR P16473 2/20 0.48
ALDH1A1 P00352 1/20 0.43
ESR1 P03372 1/20 0.43
HSD17B10 Q99714 1/20 0.43
GAA P10253 1/20 0.39
HCAR2 Q8TDS4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL3796831 1.00 TSHR (0.48) TSHRKMT2AALDH1A1ESR1HSD17B10
Maleic Acid SCHEMBL3796821 1.00 TSHR (0.48) TSHRKMT2AALDH1A1ESR1HSD17B10
SCHEMBL20073661 0.91 TSHR (0.51) TSHRKMT2AALDH1A1ESR1HSD17B10
Maleic Acid SCHEMBL3797445 0.90 KMT2A (0.41) TSHRKMT2AALDH1A1ESR1HSD17B10
Fumaric Acid SCHEMBL3797452 0.90 KMT2A (0.41) TSHRKMT2AALDH1A1ESR1HSD17B10
SCHEMBL13130571 0.80 TSHR (0.39) TSHRKMT2AALDH1A1ESR1HSD17B10
SCHEMBL3473691 0.77 TSHR (0.41) TSHRKMT2AALDH1A1ESR1HSD17B10
SCHEMBL14706863 0.74 TSHR (0.45) TSHRKMT2AALDH1A1ESR1HSD17B10
SCHEMBL15850409 0.74 TSHR (0.45) TSHRKMT2AALDH1A1ESR1HSD17B10
SCHEMBL7479511 0.74 NAAA (0.46) TSHRKMT2AALDH1A1ESR1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080253981-A1 Stabilized body care products, household products, textiles and fabrics LUPIA JOSEPH A 2008-10-16 US claimed
US-20080250572-A1 Stabilized body care products, household products, textiles and fabrics LUPIA JOSEPH A 2008-10-16 US claimed
US-20080221332-A1 Hindered Amine salt compounds WOOD MARVIN G 2008-09-11 US claimed
US-20060040836-A1 Stabilized body care products, household products, textiles and fabrics CIBA CORPORATION 2006-02-23 US claimed
US-20050234151-A1 Ink jet ink and recording material CIBA SPECIALTY CHEMICALS CORP. 2005-10-20 US claimed
WO-2005092992-A1 INK JET INK AND RECORDING MATERIAL CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2005-10-06 WO claimed
EP-2207522-B1 PERSONAL CARE AND HOUSEHOLD PRODUCT COMPOSITIONS COMPRISING SPECIFIC SULFUR CONTAINING STABILISER COMPOUNDS BASF SE (DE) 2019-11-06 EP disclosed
EP-2207522-A2 BODY-CARE AND HOUSEHOLD PRODUCTS AND COMPOSITIONS COMPRISING SPECIFIC SULFUR-CONTAINING COMPOUNDS BASF SE (DE) 2010-07-21 EP disclosed
US-7632795-B2 Stabilized body care products, household products, textiles and fabrics CIBA SPECIALTY CHEMICALS CORPORATION (US) 2009-12-15 US disclosed
US-7615503-B2 Stabilized body care products, household products, textiles and fabrics CIBA SPECIALTY CHEMICALS CORP. (US) 2009-11-10 US disclosed
US-7612026-B2 Sterically hindered amine salts having an N-(alkoxy, cycloalkoxy or aralkoxy)2,2,6,6-tetraalkylsubstituted piperidine moiety; discoloration inhibition, colorfastness CIBA SPECIALTY CHEMICALS CORP. (US) 2009-11-03 US disclosed
US-7589035-B2 Stabilized body care products, household products, textiles and fabrics CIBA SPECIALTY CHEMICALS CORPORATION (US) 2009-09-15 US disclosed
US-20090205144-A1 Stabilized body care products, household products, textiles and fabrics LUPIA JOSEPH A 2009-08-20 US disclosed
US-7410936-B2 Stabilized body care products, household products, textiles and fabrics CIBA SPECIALTY CHEMICALS CORPORATION (US) 2008-08-12 US disclosed
US-7384464-B2 Ink jet and recording material CIBA SPECIALTY CHEMICALS CORPORATION (US) 2008-06-10 US disclosed
EP-1781246-A1 STABILIZED BODY CARE PRODUCTS, HOUSEHOLD PRODUCTS, TEXTILES AND FABRICS Ciba SC Holding AG (CH) 2007-05-09 EP disclosed
WO-2006021526-A1 STABILIZED BODY CARE PRODUCTS, HOUSEHOLD PRODUCTS, TEXTILES AND FABRICS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2006-03-02 WO disclosed
US-20060040836-A1 Stabilized body care products, household products, textiles and fabrics CIBA CORPORATION 2006-02-23 US disclosed
US-20050234151-A1 Ink jet ink and recording material CIBA SPECIALTY CHEMICALS CORP. 2005-10-20 US disclosed
WO-2005092992-A1 INK JET INK AND RECORDING MATERIAL CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2005-10-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080253981-A1 Stabilized body care products, household products, textiles and fabrics DSC1, CUTA, DSG1 KMT2A 1031/4885MEN1 1581/4885TSHR 1283/4885
US-20060040836-A1 Stabilized body care products, household products, textiles and fabrics DSC1, CUTA, DSG1 KMT2A 1031/4885MEN1 1581/4885TSHR 1283/4885
US-20080221332-A1 Hindered Amine salt compounds SLC7A1, H1-0, SLC3A2 KMT2A 1462/4885MEN1 507/4885TSHR 2669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.